$451 M

INO Mkt cap, 15-Jan-2019

$2 M

Inovio Pharmaceuticals Revenue Q3, 2018
Inovio Pharmaceuticals Net income (Q3, 2018)-25 M
Inovio Pharmaceuticals EBIT (Q3, 2018)-26.6 M
Inovio Pharmaceuticals Cash, 30-Sep-201819.4 M

Inovio Pharmaceuticals Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

13.5m10.5m40.6m35.4m42.2m

Revenue growth, %

(22%)288%(79%)

R&D expense

21.4m57.8m88.7m98.6m

General and administrative expense

13.6m18.1m23.9m28.3m

Operating expense total

33.0m74.9m111.6m125.9m

EBIT

(19.5m)(39.5m)(34.3m)(76.2m)(83.6m)

EBIT margin, %

(145%)(378%)(85%)(216%)(198%)

Interest income

132.2k113.2k305.1k1.3m1.6m

Income tax expense

2.1m

Net Income

(66.1m)(36.1m)(29.1m)(73.7m)(88.2m)

Inovio Pharmaceuticals Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

33.7m40.5m57.6m19.1m23.8m

Accounts Receivable

3.3m2.8m7.3m15.8m6.0m

Inventories

637.4k798.0k917.3k1.7m

Current Assets

58.7m98.9m171.9m124.6m138.4m

PP&E

2.9m7.3m18.3m

Goodwill

10.1m10.1m10.1m10.5m10.5m

Total Assets

88.3m131.8m213.8m173.7m187.2m

Accounts Payable

5.4m6.4m13.1m19.6m23.3m

Short-term debt

Current Liabilities

29.0m14.0m31.5m43.8m35.4m

Long-term debt

Total Debt

Total Liabilities

35.4m37.9m50.3m44.8m

Additional Paid-in Capital

348.1m443.3m534.0m556.7m665.8m

Retained Earnings

(295.8m)(331.9m)(361.1m)(434.8m)(523.4m)

Total Equity

52.9m111.5m175.9m123.4m142.5m

Financial Leverage

1.7 x1.2 x1.2 x1.4 x1.3 x

Inovio Pharmaceuticals Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(66.1m)(36.1m)(29.1m)(73.7m)(88.2m)

Depreciation and Amortization

2.1m1.6m1.9m3.1m3.5m

Accounts Receivable

(2.5m)499.2k(4.5m)(8.5m)9.8m

Inventories

(229.7k)(160.5k)(119.3k)(831.8k)

Accounts Payable

2.2m1.5m6.5m6.4m2.8m

Cash From Operating Activities

(15.4m)(29.8m)(12.4m)(62.6m)(63.2m)

Cash From Investing Activities

(9.2m)(35.8m)(54.8m)16.3m(27.8m)

Cash From Financing Activities

52.7m72.5m84.4m7.8m95.7m

Inovio Pharmaceuticals Ratios

USDY, 2018

Financial Leverage

1.4 x
Report incorrect company information

Inovio Pharmaceuticals Operating Metrics

FY, 2016

Patents Issued

620
Report incorrect company information

Inovio Pharmaceuticals Employee Rating

4.17 votes
Culture & Values
4.0
Work/Life Balance
4.5
Senior Management
4.3
Salary & Benefits
3.2
Career Opportunities
3.2
Source